SAEs with treatment discontinuation in the FCCam arm
. | Events . | Occurrence . |
---|---|---|
Mucormycosis | 1 | After cycle 6 |
Diffuse large B-cell lymphoma | 3 | After cycles 4 and 5 |
EBV-associated lymphoproliferative disorder | 1 | After cycle 5 |
Heart failure during neutropenia | 2 | After cycle 2 |
Septic shock (Pseudomonas aeruginosa) | 1 | After end of evaluation |
Gastrointestinal stromal tumor | 1 | After end of evaluation |
Ocular toxoplasmosis | 1 | After cycle 6 |
Pneumococcal sepsis | 1 | After cycle 1 |
Pneumonia/Clostridium difficile colitis | 1 | After cycle 5 |
Respiratory insufficiency | 1 | After end of evaluation |
Subdural hematoma | 1 | After cycle 1 |
Tumor lysis syndrome | 1 | After cycle 1 |
. | Events . | Occurrence . |
---|---|---|
Mucormycosis | 1 | After cycle 6 |
Diffuse large B-cell lymphoma | 3 | After cycles 4 and 5 |
EBV-associated lymphoproliferative disorder | 1 | After cycle 5 |
Heart failure during neutropenia | 2 | After cycle 2 |
Septic shock (Pseudomonas aeruginosa) | 1 | After end of evaluation |
Gastrointestinal stromal tumor | 1 | After end of evaluation |
Ocular toxoplasmosis | 1 | After cycle 6 |
Pneumococcal sepsis | 1 | After cycle 1 |
Pneumonia/Clostridium difficile colitis | 1 | After cycle 5 |
Respiratory insufficiency | 1 | After end of evaluation |
Subdural hematoma | 1 | After cycle 1 |
Tumor lysis syndrome | 1 | After cycle 1 |